Products
Liraglutide (5-31) TFA / Liraglutide (8-31) TFA (Victoza, GLP-1 receptor agonist)-Therapeutic peptides drug benchmark for in-vivo/in-vitro study
Cat No.: GMP-Bios-peptide-003 (GMP-Bios-peptide-003-1 / GMP-Bios-peptide-003-2) Product Name: Liraglutide (5-31) TFA / Liraglutide (8-31) TFA Structural formula:
Liraglutide TFA, the trifluoroacetic acid salt form of Liraglutide. Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist also known as incretin mimetics. Liraglutide, sold under the brand name Victoza among others, is an anti-diabetic medication used to treat type 2 diabetes, obesity, and chronic weight management. It works by increasing insulin release from the pancreas and decreases excessive glucagon release. Liraglutide was approved for medical use in the European Union in 2009, and in the United States in 2010.
Order information
| Catalog No. | Desciption | Price(In USD) | Qty (Quantity) | Sum(In USD) |
|---|---|---|---|---|
| GMP-Bios-peptide-003-1-5mg | Liraglutide (5-31) TFA Size:5mg | 780 | ||
| GMP-Bios-peptide-003-1-25mg | Liraglutide (5-31) TFA Size:25mg | 1950 | ||
| GMP-Bios-peptide-003-1-50mg | Liraglutide (5-31) TFA Size:50mg | 2925 | ||
| GMP-Bios-peptide-003-1-100mg | Liraglutide (5-31) TFA Size:100mg | 3900 | ||
| GMP-Bios-peptide-003-1-500mg | Liraglutide (5-31) TFA Size:500mg | 7800 | ||
| GMP-Bios-peptide-003-2-5mg | Liraglutide (8-31) TFA Size:5mg | 780 | ||
| GMP-Bios-peptide-003-2-25mg | Liraglutide (8-31) TFA Size:25mg | 1950 | ||
| GMP-Bios-peptide-003-2-50mg | Liraglutide (8-31) TFA Size:50mg | 2925 | GMP-Bios-peptide-003-2-100mg | Liraglutide (8-31) TFA Size:100mg | 3900 | GMP-Bios-peptide-003-2-500mg | Liraglutide (8-31) TFA Size:500mg | 7800 |
| GMP-Bios-peptide-003-1/2-xmg | Size≥500mg | Inquiry | ||
| Shipping Cost: | 760.00 | |||
| Total: | ||||
Description
| Product Name | Liraglutide (5-31) TFA / Liraglutide (8-31) TFA |
| Brand name | Victoza |
| CAS No. | 204656-20-2 |
| Formula | C157H247N37O44 • C2HF3O2 / C140H224N34O39 • C2HF3O2 |
| Biological Activity | Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist also known as incretin mimetics. |
| Purity | Purity: ≥98% (HPLC) |
| Application | Therapeutic peptides drug benchmark or raw material for peptide drugs or peptide conjugation drugs discovery and development. |
| Predicted Molecular Mass | 3356.86 / 3007.48 |
| Formulation & Reconstitution | Powder |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
<